JEREMY BOOKMAN: Open Payments
NPI 1427394089 · SEABROOK, NH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$9,841 in 160 payments from 13 companies in 2025. Trend: 2023 $18,414 · 2024 $21,866 · 2025 $9,841
Speaker / faculty: $5,500Food & beverage: $4,310Education: $31
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 28 | $6,251 |
| Neurocrine BioSciences, Inc. | 18 | $608 |
| Alkermes, Inc. | 18 | $578 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $485 |
| Otsuka America Pharmaceutical, Inc. | 18 | $444 |
| Lundbeck LLC | 17 | $355 |
| Axsome Therapeutics, Inc. | 14 | $352 |
| Vanda Pharmaceuticals Inc. | 19 | $329 |
| ABBVIE INC. | 4 | $156 |
| E.R. Squibb & Sons, L.L.C. | 6 | $137 |
Products named: INVEGA SUSTENNA, REXULTI, INGREZZA, CAPLYTA, Auvelity, FANAPT, SPRAVATO, LYBALVI.
Industry payments across NH — which companies pay providers there.
